Similarly, TGF-β was significantly more expressed in the iPS group than in the CKD group (p < 0.01) although numerically, the relative mean expression of TGF-β transcripts was twofold greater in IPSs than in BMSCs. Here, TGFB1 is linked to chronic kidney disease.